Could the makeup of medical teams help explain why Black patients are more likely than white patients to die after heart surgery in the same hospitals?
Frankel Cardiovascular Center
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
When researchers study rare diseases, breakthroughs can be made that help patients. Revisit studies that are putting genetic puzzle pieces together to tackle these conditions.
New research suggests LVADs may not solve mitral regurgitation for some patients with poor right heart function.
Upon uncovering that inadequate blood flow can be a more imminent, life-threatening problem than aortic rupture for some patients, doctors emerge with a new procedural method.